Minister K. Muraleedharan Visits BRIC-RGCB Campus
Minister for Health and Devaswoms, Shri K. Muraleedharan, has said that the advanced research facilities at the Biotechnology Research and Innovation Centre–Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) played a crucial role in preventing an Ebola outbreak in Kerala.
During his visit to the BRIC-RGCB campus at Akkulam on Sunday evening, the Minister highlighted the institution’s significant contribution to the state’s healthcare sector. He noted that the government aims to build a “Healthy Kerala” and said the cutting-edge facilities at BRIC-RGCB are instrumental in achieving that vision.
Rapid Testing Helped Contain Ebola Threat
Recalling the recent Ebola scare, Shri Muraleedharan said BRIC-RGCB enabled authorities to conduct critical testing within a short time frame.
“We were able to conduct an Ebola test within 12 hours after receiving samples from Kozhikode. Moreover, within four hours, we obtained a negative result before the final confirmation arrived from the laboratory in Pune,” he said.
The Minister commended the efforts of the scientists and researchers, adding that no second Ebola suspect case has been reported in the state.
Tour of Advanced Research Facilities
During the visit, Shri Muraleedharan toured several key facilities on the campus, including the BSL-3 laboratory, the National Facility for Recombinant Cells and Sensors, and the Malaria Research Laboratory.
Meanwhile, as per the press release, BRIC-RGCB Director Dr. Beena Pillai presented an overview of the institution’s growth trajectory and major scientific achievements.
Focus on Emerging Health Challenges
Highlighting ongoing research initiatives, Dr. Pillai outlined the Centre’s work in cardiovascular diseases, the Human Papillomavirus (HPV) vaccine, and malaria. She also emphasized the need to prepare for future healthcare challenges, particularly in mental health.
Noting demographic trends, Dr. Pillai said that by 2050, one in five Indians is expected to be a senior citizen. Consequently, BRIC-RGCB plans to expand its research efforts to address age-related mental health concerns.
She also showcased the Centre’s AI-driven design platforms for RNA and protein-based biomanufacturing products with patent potential. In addition, she highlighted BRIC-RGCB’s cancer research collaborations with leading institutions, including the Cochin Cancer Research Centre.
Virology and Diagnostic Capabilities Highlighted
Dr. Radhakrishnan R., Head of Grade I Virology, Laboratory Medicine and Molecular Diagnostics (LMMD), explained the infectious disease testing capabilities available at BRIC-RGCB and their role in strengthening public health preparedness.
Scientists, research professionals, academicians, and students attended the programme.